Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director James T. Treace acquired 50,000 shares of Treace Medical Concepts stock in a transaction dated Tuesday, May 28th. The stock was purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the purchase, the director now […]

Related Keywords

United States , Stifel Nicolaus , Jamest Treace , Treace Medical Concepts Inc , Quest Partners , Treace Medical Concepts Company Profile , Timessquare Capital Management , Gabelli Funds , Walleye Capital , Nasdaq , Qube Research Technologies Ltd , Jpmorgan Chase Co , Treace Medical Concepts , Get Free Report , Director James , Medical Concepts , Treace Medical , Square Capital Management , Technologies Ltd , Treace Medical Concepts Daily ,